T. Rowe Price Associates’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $475K | Sell |
|
|||||
|
2025
Q1 | $203K | Buy |
|
|||||
|
2024
Q4 | $247K | Buy |
|
|||||
|
2024
Q3 | $128K | Hold |
|
|||||
|
2024
Q2 | $222K | Buy |
|
|||||
|
2024
Q1 | $151K | Hold |
|
|||||
|
2023
Q4 | $108K | Hold |
|
|||||
|
2023
Q3 | $71K | Sell |
|
|||||
|
2023
Q2 | $70K | Sell |
|
|||||
|
2023
Q1 | $104K | Sell |
|
|||||
|
2022
Q4 | $1.09M | Buy |
|
|||||
|
2022
Q3 | $361K | Buy |
|
|||||
|
2022
Q2 | $146K | Buy |
|
|||||
|
2022
Q1 | $596K | Sell |
|
|||||
|
2021
Q4 | $2.38M | Buy |
|
|||||
|
2021
Q3 | $1.25M | Buy |
|